Database

Startups

Main Industry
Health Care
Main Product/Service
AMS BioteQ offers advanced antimicrobial and wound‑care products including a novel natural antibacterial ingredient MediAce®, and a hydrophilic dressing series called SIPSIP™ (Foam / Pro / Complex) which deliver features such as high absorbency, anti‑adhe
Founded Year
2018
Unified Business No.
42814751
Status
Active
Number of Employees
0
Total Paid-in Capital
325,347,500 (NT$)
Location of Company
Taiwan , Kaohsiung City
Exit Status
Emerging Stock Exchange(2021)
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, Ministry of Economic Affairs.
Introduction
AMS BioteQ Co., Ltd., founded in 2018 and headquartered in Taiwan, is a biotechnology company focused on combating antibiotic resistance and developing antimicrobial solutions by leveraging its proprietary bio‑engineering technology platform called ExtrO™



More2 ↓

Similar Companies

TAIWAN BIO THERAPEUTICS INC.

Leveraging the FAST CGT platform to enhance the specificity, persistence, and stability of regulatory T cells, improving their ability to restore immune tolerance and suppress inflammation as a targeted alternative to non-selective, high-risk immunosuppre

GenomeFrontier Therapeutics TW Co., Ltd.

GenomeFrontier’s product pipeline is built around its Quantum Engine™, which integrates four core platforms: Quantum Nufect™ (gentle, efficient gene delivery), Quantum pBac™ (high-capacity non-viral gene integration), iCellar™ (robust cell expansion), and

Ochre Bio Taiwan Ltd

Ochre Bio’s key technology pillars include a Human Discovery Platform (combining patient liver data with gene perturbation atlases), a Human Validation Platform (using perfused livers, diseased tissue slices, and primary cells), and an RNA Therapeutics Pl
:::